Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$271.6 - $314.21 $9.24 Million - $10.7 Million
-34,019 Reduced 64.95%
18,362 $5.77 Million
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $12.5 Million - $14 Million
-45,536 Reduced 46.5%
52,381 $14.7 Million
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $21.3 Million - $23.5 Million
84,533 Added 631.6%
97,917 $27 Million
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $485,031 - $556,419
-2,595 Reduced 16.24%
13,384 $2.72 Million
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $6.31 Million - $7.6 Million
-37,752 Reduced 70.26%
15,979 $3.01 Million
Q2 2020

Aug 12, 2020

BUY
$113.31 - $182.44 $4.66 Million - $7.5 Million
41,086 Added 324.92%
53,731 $8.93 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $195,849 - $207,984
1,198 Added 10.47%
12,645 $2.14 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $1.83 Million - $2.04 Million
11,447 New
11,447 $1.92 Million
Q2 2019

Aug 12, 2019

SELL
$144.16 - $172.9 $2.55 Million - $3.06 Million
-17,697 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$123.7 - $156.3 $1.66 Million - $2.1 Million
13,410 Added 312.81%
17,697 $2.71 Million
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $268,582 - $387,002
2,223 Added 107.7%
4,287 $542,000
Q3 2018

Nov 09, 2018

BUY
$167.67 - $188.27 $133,297 - $149,674
795 Added 62.65%
2,064 $358,000
Q2 2018

Aug 08, 2018

BUY
$160.33 - $189.41 $203,458 - $240,361
1,269 New
1,269 $228,000
Q4 2017

Feb 09, 2018

SELL
$147.99 - $163.95 $552,742 - $612,353
-3,735 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $558,270 - $599,691
3,735
3,735 $564,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.